Evidence map›Paper›PMID 39996716›Full record

ArticleCells2025

Promegestone Prevents Lipopolysaccharide-Induced Cervical Remodeling in Pregnant Mice.

Amna Nadeem, Lubna Nadeem, Stephen James Lye, Oksana Shynlova

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amna NadeemDepartment of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Lubna NadeemSinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, ON M5G 1X5, Canada.
Stephen James LyeDepartment of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Oksana ShynlovaDepartment of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada.ORCID 0000-0002-6084-8156

Funding

CIHR 143262CIHR 150735
6 · The paper itself

Abstract

In most mammals, a withdrawal of the pro-gestational hormone progesterone (P4) is necessary for labor onset. In murine cervix, P4 withdrawal is mediated by enzymes steroid 5-alpha-reductase type 1 (SRD5A1) and 20-alpha-hydroxysteroid-dehydrogenase (20α-HSD). Previously, we have shown that inflammatory stimuli induce 20α-HSD levels in uterine muscle (myometrium). Here, we hypothesized that (1) infectious inflammation alters the levels of both P4-metabolizing enzymes in mouse cervix, which consequently ceases P4-mediated inhibition of cervical remodeling, thereby inducing preterm labor (PTL); (2) a progestin, selective progesterone receptor modulator promegestone (aka R5020), non-metabolizable by 20α-HSD, can block lipopolysaccharide (LPS)-induced PTL in mice by maintaining P4 signaling and preventing cervical remodeling. Using RT-PCR and IHC/IF methods, we evaluated the effect of inflammation on the expression of both enzymes in mouse cervix and determined if R5020 can prevent cervical remodeling and PTL in mice. We found significant induction of SRD5A1 and 20α-HSD proteins (

Indexed as

Cervix UteriLipopolysaccharidesPromegestone20-alpha-Hydroxysteroid Dehydrogenase3-Oxo-5-alpha-Steroid 4-DehydrogenaseAnimalsFemaleInflammationMiceObstetric Labor, PrematurePregnancyProgesterone20-alpha-Hydroxysteroid Dehydrogenase3-Oxo-5-alpha-Steroid 4-DehydrogenaseLipopolysaccharidesProgesteronePromegestone20α-HSDcervical remodelingcytokineslipopolysaccharide (LPS)mouse modelspreterm laborprogesteronepromegestone/R5020steroid metabolismuterus

Identifiers

PMID39996716
PMCPMC11853409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.